| Date | Time | Source | Headline | Symbol | Company |
| 11/10/2010 | 8:00AM | Business Wire | Forest Laboratories, Inc. Announces Executive Management Promotions & Retirement of Lawrence Olanoff as President & Chief Ope... | NYSE:FRX | Forest Road Acquisition Corp |
| 11/09/2010 | 11:56AM | Edgar (US Regulatory) | Quarterly Report (10-Q) | NYSE:FRX | Forest Road Acquisition Corp |
| 11/01/2010 | 4:59PM | Dow Jones News | Ironwood, Forest Report Second Success In Irritable Bowel Treatment | NYSE:FRX | Forest Road Acquisition Corp |
| 11/01/2010 | 4:30PM | Business Wire | Ironwood & Forest Announce Positive Linaclotide Results from Second Phase 3 Trial in Patients with Irritable Bowel Syndrome w... | NYSE:FRX | Forest Road Acquisition Corp |
| 10/29/2010 | 6:18PM | Business Wire | Forest Announces FDA Approval of Teflaro™ (ceftaroline fosamil) for the Treatment of Community-Acquired Bacterial Pneumonia... | NYSE:FRX | Forest Road Acquisition Corp |
| 10/29/2010 | 8:10AM | Dow Jones News | CORRECT: Shire To Press On With Vyvanse In Depression | NYSE:FRX | Forest Road Acquisition Corp |
| 10/29/2010 | 7:30AM | Dow Jones News | Shire To Press On With Vyvanse In Depression Despite Miss | NYSE:FRX | Forest Road Acquisition Corp |
| 10/29/2010 | 2:00AM | Business Wire | Forest & Almirall Report Preliminary Topline Results from the ACCORD COPD II Phase III Study of aclidinium bromide in Chronic... | NYSE:FRX | Forest Road Acquisition Corp |
| 10/25/2010 | 11:05AM | Dow Jones News | 2nd UPDATE: AstraZeneca Starts Mid-Stage Trial Of CytoFab | NYSE:FRX | Forest Road Acquisition Corp |
| 10/19/2010 | 1:35PM | Edgar (US Regulatory) | Current report filing (8-K) | NYSE:FRX | Forest Road Acquisition Corp |
| 10/19/2010 | 8:55AM | Dow Jones News | Forest Labs 2Q Net Up 53% Amid 2009 Charges; EPS View Raised | NYSE:FRX | Forest Road Acquisition Corp |
| 10/19/2010 | 8:00AM | Business Wire | Forest Laboratories, Inc. Reports Second Quarter Fiscal Year 2011 Earnings Per Share of $1.00 | NYSE:FRX | Forest Road Acquisition Corp |
| 10/11/2010 | 1:23PM | Dow Jones News | UPDATE: FDA Wants More Data For Jazz Pharma Fibromyalgia Drug | NYSE:FRX | Forest Road Acquisition Corp |
| 10/04/2010 | 9:31AM | Business Wire | Forest Laboratories, Inc. Sets Date and Conference Call for Fiscal 2011 Second Quarter Earnings | NYSE:FRX | Forest Road Acquisition Corp |
| 09/21/2010 | 9:42PM | Dow Jones News | UPDATE: DOJ Tries To Intervene In 'Off-Label' Case Against Pfizer | NYSE:FRX | Forest Road Acquisition Corp |
| 09/21/2010 | 3:27PM | Dow Jones News | DOJ Tries To Intervene In 'Off-Label' Case Against Pfizer | NYSE:FRX | Forest Road Acquisition Corp |
| 09/20/2010 | 11:31AM | Edgar (US Regulatory) | Current report filing (8-K) | NYSE:FRX | Forest Road Acquisition Corp |
| 09/17/2010 | 11:53AM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NYSE:FRX | Forest Road Acquisition Corp |
| 09/15/2010 | 5:53PM | Dow Jones News | 2nd UPDATE: Forest Labs To Pay $313 Million To Settle US Charges | NYSE:FRX | Forest Road Acquisition Corp |
| 09/15/2010 | 4:11PM | Dow Jones News | UPDATE: Forest Labs To Pay $313 Million To Settle US Charges | NYSE:FRX | Forest Road Acquisition Corp |
| 09/15/2010 | 3:36PM | Dow Jones News | Forest Labs To Pay $313 Million To Settle US Charges - Justice Dept | NYSE:FRX | Forest Road Acquisition Corp |
| 09/15/2010 | 2:36PM | Business Wire | Forest Laboratories, Inc. Finalizes Previously Disclosed Settlement of U.S. Government Investigations & Related Civil Qui Tam... | NYSE:FRX | Forest Road Acquisition Corp |
| 09/13/2010 | 6:37PM | Dow Jones News | Ironwood Announces Positive Phase 3 Results, Shares Jump | NYSE:FRX | Forest Road Acquisition Corp |
| 09/13/2010 | 5:41PM | Business Wire | Ironwood & Forest Announce Positive Linaclotide Results from Phase 3 Trial in Patients with Irritable Bowel Syndrome with Con... | NYSE:FRX | Forest Road Acquisition Corp |
| 09/13/2010 | 7:00AM | Business Wire | Forest Responds to FDA Complete Response Letter for Roflumilast | NYSE:FRX | Forest Road Acquisition Corp |
| 09/07/2010 | 4:55PM | Business Wire | FDA Advisory Committee Recommends Approval of Forest Laboratories’ Ceftaroline Fosamil for the Treatment of Community Acqui... | NYSE:FRX | Forest Road Acquisition Corp |
| 09/07/2010 | 9:31AM | PR Newswire (US) | Seven Summits Research Releases Comments on Apple, Hewlett-Packard, Forest Laboratories, Shanda Interactive and Men's Wearhouse | NYSE:FRX | Forest Road Acquisition Corp |
| 09/01/2010 | 11:06AM | Dow Jones News | Nycomed's Lung Drug Daxas Launched In Germany, UK Is Next | NYSE:FRX | Forest Road Acquisition Corp |
| 08/30/2010 | 2:00AM | Business Wire | Forest Laboratories, Inc. & Gedeon Richter Plc Announce Results from a Phase II Study of Cariprazine for the Treatment of Bip... | NYSE:FRX | Forest Road Acquisition Corp |
| 08/25/2010 | 9:52AM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NYSE:FRX | Forest Road Acquisition Corp |